Advertisement

Picture Swiss Biotech Association LSG Swiss Biotech Days 2025 Basel 650x100px
Organisation › Details

InfanDx AG, Berlin Office

InfanDx AG is a privately held company focusing on the development and commercialization of novel diagnostic solutions for acute and critical care conditions in newborns. The Company’s proprietary lead product in clinical development is the InfanDx HypoxE® Test designed for the reliable identification of hypoxic-ischemic encephalopathy (HIE) within the first hours of birth. HIE as a consequence of perinatal asphyxia (oxygen deficit during birth) can result in life-long disabilities. The long-term detrimental effects of HIE can be mitigated and even prevented by neuroprotective hypothermia treatment. However, this therapy must be initiated within six hours of birth to be effective, requiring suitable diagnostic methods to reliably and timely identify the affected newborns. While standard-of-care diagnostic methods cannot deliver a conclusive diagnosis of HIE within this time frame, the rapid InfanDx HypoxE® Test is designed to support clinicians in the timely decision whether newborns require neuroprotective hypothermia treatment. The Company is headquartered in Cologne, Germany, with a branch office in Berlin, Germany, and a wholly-owned subsidiary in Boston, MA, USA. *

 

Period Start 2022-03-15 existent
  Group InfanDx (Group)
Products Industry neonatal test
  Industry 2 biomarker
Person Person Plum, Achim (High-Tech Gründerfonds 202501– Managing Director before InfanDx + SphingoTec + Curetis/OpGen + Siemens)
     
Region Region Berlin
  Country Germany
  City n. a. Berlin
    Address record changed: 2022-03-23
     
Basic data Employees n. a.
     
    * Document for »About Section«: InfanDx AG. (3/15/22). "Press Release: Neonatal Diagnostics Company InfanDx AG Closes Oversubscribed Second Tranche of Series A". Cologne & Boston, MA.
     
   
Record changed: 2024-12-29

Advertisement

Picture Berlin Partner Events RegMed Forum 2025 HealthCapital 650x200px

More documents for InfanDx (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x300px




» top